Latest Stock Market News

Hemang Jani, suggests that ITC is still cheaper than its peers, and with its solid performance across divisions, it is still the best time for investors to hold onto ITC. Jani also maintains a positive bias on Maruti and Ashok Leyland in the auto sector, as despite the relatively higher base, he believes it will deliver strong earnings growth.

ICICI Bank has outperformed BSE Sensex, Nifty50 and banking indices Nifty Bank and BSE Bankex, registering over 21% returns over the past 12 months amid robust Q4 earnings and technical triggers. According to Rajesh Palviya, VP of Technical and Derivatives Research at Axis Securities, the stock is in a strong uptrend across all time frames, with a series of higher tops and bottoms, rebounding sharply after recapturing its 20, 50, 100, and 200-day SMA. Sharekhan maintains a "Buy" rating on ICICI Bank with a target price of Rs 1,120. Key risks include economic slowdown, slower loan growth, and lower margins.

The cement stock hit a record high of Rs 598 on 9th December 2022 but failed to hold on to the momentum. The stock found support above Rs 320 levels in February 2023 and bounced back but it failed to clear resistance around Rs 400 levels.

So, apart from aggressive store opening we will also have these four parameters play out in a significant number of stores and we do expect again a very high double digit for Starbucks as well.

The pandemic-induced rally in the stock market led to explosive growth in the number of demat accounts, with many novice investors trading recklessly on the basis of ads offering "trading as a profession." However, the vast majority of retail investors do not get good returns from the market because they invest in cheap low-grade stocks and do not conduct research. Moreover, the vast majority of traders lose money in reckless overtrading, with a recent SEBI study finding that 89% of traders in the equity F&O segment lost money in FY22. Only disciplined, systematic investment in high-quality stocks/mutual funds can result in good returns over the long term.

Axis Bank’s Q4 earnings are expected to be impacted by the one-off costs due to the integration of Citibank India’s business, leading to net losses, according to some analysts. The estimated net loss ranges from INR 54.12bn to INR 55.26bn, while others have excluded the integration costs from their calculations. The bank’s strong core performance is projected despite one-off costs, led by high double-digit growth in net interest income, lower bad loans, and net interest margin. Key items to watch from the management include business plans, near-term growth trends, and margin trajectory.

​There are other parts of the emerging markets universe where you are actually getting superior growth outlook for the next couple of years at far compelling valuations. So yes, we still have India as an underweight in our EM universe.

Shares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had reported, citing sources that Fosun Pharma was considering a sale of Gland Pharma after receiving interest from potential buyers.

The Nifty Bank index was trading 0.15 per cent down at 42615.65.

On the technical charts, the RSI of the stock stood at 50.33.